President-elect Donald Trump’s return to the White House might favourably impact the psychedelics sector with ASX stocks in ...

Argonaut's Hayden Bairstow predicts more Australian gold M&A could be on the horizon, with mergers likely for single asset ...

Retail investors can access private tech via two ASX stocks with Scalare providing support and Bailador targeting returns.

China has escalated a trade war with the US, suspending gallium, germanium and antimony exports. That's another tailwind for ...

Pro Medicus founders Dr Sam Hupert and Anthony Hall have lightened their holdings, but they still account for close to half ...

A new government initiative will see a mandatory SMS Sender ID Register implemented by the Australian Communications and ...

Gold and copper remain key pillars of Victor Smorgon Group's investing strategy, with gold miners "printing cash" the target.

Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...

Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing bonanza results at the Muckanippie project from ...

ASX rebounds slightly after weak GDP data as RBA rate cut talks grow, while Rio Tinto and Sumitomo strike a $615m copper deal.

Kristie Batten chatted with mining bigwigs Bill Beament and Simon Lawson on Trump's impact on miners, gold M&A and more.

A heavy mineral sands discovery and Chinese critical minerals export ban have junior resources stocks running hot.